Different efficacy of various blocking reagents to eliminate interferences by human antimouse antibodies with a two-site immunoassay
- 1 April 1996
- journal article
- research article
- Published by Elsevier in Clinical Biochemistry
- Vol. 29 (2) , 145-148
- https://doi.org/10.1016/0009-9120(95)02044-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Interference by Human Antibodies with Tumor Marker AssaysHybridoma, 1995
- Heterologous double-determinant immunoradiometric assay CA 125 II: reliable second-generation immunoassay for determining CA 125 in serumClinical Chemistry, 1993
- Monitoring cancer antigen 125 in serum of ovarian cancer patients after administration of 131I-labeled F(ab')2 fragments of OC125 antibodyClinical Chemistry, 1993
- Heterophilic antibodies in human sera causing falsely increased results in the CA 125 immunofluorometric assayClinical Chemistry, 1990
- Interference by human anti-mouse antibody in two-site immunoassaysClinical Chemistry, 1990
- Heterophilic antibodies: a problem for all immunoassays.Clinical Chemistry, 1988
- Immunotherapy of pancreatic cancer with monoclonal antibody BW 494International Journal of Cancer, 1988
- Incidence and specificity of interference in two-site immunoassays.Clinical Chemistry, 1986
- Circulating antibodies to mouse monoclonal immunoglobulins in normal subjects--incidence, species specificity, and effects on a two-site assay for creatine kinase-MB isoenzyme.Clinical Chemistry, 1986
- Incidence and mechanism of spurious increase in serum thyrotropin.Clinical Chemistry, 1982